Conclusions regarding relative cost-utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are premature

Thomas E. Delea; Jonathan Karnon; Paul E. Goss

doi:10.1093/annonc/mdl171

Conclusions regarding relative cost-utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are premature

Thomas E. Delea, Jonathan Karnon, Paul E. Goss

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

We read with interest the study by Lønning [1] examining the cost–utility of aromatase inhibitors as adjuvant therapy in postmenopausal women with early breast cancer. We are concerned, however, with the validity of the analysis, its results and conclusions.

Original language	English
Pages (from-to)	197-198
Number of pages	2
Journal	Annals of Oncology
Volume	18
Issue number	1
DOIs	https://doi.org/10.1093/annonc/mdl171
Publication status	Published - Jan 2007
Externally published	Yes

Keywords

Aromatase inhibitors
postmenopause
Breast cancer

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdl171Licence: In Copyright

Cite this

@article{83be176ac0d84343975d5ea9a11832d7,

title = "Conclusions regarding relative cost-utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are premature",

abstract = "We read with interest the study by L{\o}nning [1] examining the cost–utility of aromatase inhibitors as adjuvant therapy in postmenopausal women with early breast cancer. We are concerned, however, with the validity of the analysis, its results and conclusions.",

keywords = "Aromatase inhibitors, postmenopause, Breast cancer",

author = "Delea, {Thomas E.} and Jonathan Karnon and Goss, {Paul E.}",

year = "2007",

month = jan,

doi = "10.1093/annonc/mdl171",

language = "English",

volume = "18",

pages = "197--198",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier BV",

number = "1",

}

TY - JOUR

T1 - Conclusions regarding relative cost-utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are premature

AU - Delea, Thomas E.

AU - Karnon, Jonathan

AU - Goss, Paul E.

PY - 2007/1

Y1 - 2007/1

N2 - We read with interest the study by Lønning [1] examining the cost–utility of aromatase inhibitors as adjuvant therapy in postmenopausal women with early breast cancer. We are concerned, however, with the validity of the analysis, its results and conclusions.

AB - We read with interest the study by Lønning [1] examining the cost–utility of aromatase inhibitors as adjuvant therapy in postmenopausal women with early breast cancer. We are concerned, however, with the validity of the analysis, its results and conclusions.

KW - Aromatase inhibitors

KW - postmenopause

KW - Breast cancer

U2 - 10.1093/annonc/mdl171

DO - 10.1093/annonc/mdl171

M3 - Article

SN - 0923-7534

VL - 18

SP - 197

EP - 198

JO - Annals of Oncology

JF - Annals of Oncology

IS - 1

ER -

Conclusions regarding relative cost-utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are premature

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this